Health Affairs, 24, no. 3 (2005): 653-665 doi: 10.1377/hlthaff.24.3.653 © 2005 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Berndt, E. R. Articles by Hurvitz, J. A. Search for Related Content PubMed PubMed Citation Articles by Berndt, E. R. Articles by Hurvitz, J. A. Related Collections Consumer Issues Health Promotion/Disease Prevention International Issues Vaccines Public Health Research And Technology

Financing

Vaccine Advance-Purchase Agreements For Low-Income Countries: Practical Issues

There are strong theoretical arguments for the creation of advance-purchase agreements to increase incentives for the development and production of vaccines for diseases concentrated in low-income countries. A Center for Global Development working group recently concluded that such agreements could be implemented successfully. We consider the practical economic and legal arrangements for such advance-purchase commitments. We identify several practical issues that we believe the public health and policy community should consider further in the design of an advance-purchase commitment.

                      What's this?

This article has been cited by other articles:

				K. Outterson and A. S. Kesselheim Market-Based Licensing For HPV Vaccines In Developing Countries Health Aff., January 1, 2008; 27(1): 130 - 139. [Abstract] [Full Text] [PDF]

				D. B. Ridley, H. G. Grabowski, and J. L. Moe Developing drugs for developing countries. Health Aff., March 1, 2006; 25(2): 313 - 324. [Abstract] [Full Text] [PDF]

				A. Batson The Problems And Promise Of Vaccine Markets In Developing Countries Health Aff., May 1, 2005; 24(3): 690 - 693. [Abstract] [Full Text] [PDF]